| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,687 |
12,935 |
$1.14M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12,655 |
12,152 |
$865K |
| 99070 |
|
9,671 |
7,971 |
$189K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
252 |
251 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
604 |
548 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
173 |
158 |
$10K |
| 99000 |
|
14,473 |
11,363 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
175 |
163 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,790 |
1,592 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
141 |
133 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
873 |
764 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
330 |
301 |
$1K |
| 81003 |
|
1,267 |
1,183 |
$502.22 |
| 99051 |
|
2,696 |
2,564 |
$355.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
51 |
47 |
$274.52 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
270 |
259 |
$244.38 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
25 |
24 |
$205.24 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$151.86 |
| A6203 |
Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
147 |
125 |
$120.24 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
108 |
52 |
$100.90 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$71.88 |
| 82962 |
|
65 |
60 |
$18.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
13 |
$0.18 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
12 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
296 |
290 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$0.00 |
| A4550 |
Surgical trays |
80 |
70 |
$0.00 |
| 99072 |
|
417 |
371 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
13 |
13 |
$0.00 |
| 99354 |
|
12 |
12 |
$0.00 |